Market selloffs can feel ruthless in the moment. But for long-term investors, they also open the door to some of the best opportunities — especially when it comes to quality ASX growth shares trading at a discount.
Right now, several of the ASX's most promising companies have been dragged down by broader market weakness, despite their businesses continuing to grow.
Here are three ASX growth shares analysts think investors should buy while they're still on sale.
Life360 Inc. (ASX: 360)
Life360 has quietly become one of the most exciting tech stories on the ASX. Best known for its eponymous family safety app, the company is growing fast in the U.S. and expanding internationally, with paid subscriber numbers rising rapidly.
While the recent tech selloff has pulled its share price back, this has nothing to do with its performance. Life360 continues to deliver strong top-line growth and improving unit economics. For investors chasing exposure to global SaaS with sticky customers and recurring revenue, Life360 looks like a compelling opportunity at current levels.
Goldman Sachs rates it as a buy with a $27.00 price target. This compares favourably to its current share price of $19.00.
Pro Medicus Ltd (ASX: PME)
Pro Medicus is no stranger to premium valuations — and for good reason. The health imaging software provider boasts jaw-dropping margins, long-term contracts with some of the world's top hospitals, and zero debt on its balance sheet.
Its Visage imaging platform is used by radiologists across the U.S., Europe, and beyond, and demand continues to grow as healthcare providers seek more efficient and scalable solutions.
Pro Medicus shares have pulled back massively from their highs in line with the broader tech sector, but the business itself keeps powering ahead. For those willing to take a long-term view, this could be a rare chance to buy one of the ASX's true compounders at a discount.
Bell Potter is bullish on Pro Medicus and has a buy rating and $280.00 price target. At present, its shares are changing hands for $204.18.
WiseTech Global Ltd (ASX: WTC)
Finally, WiseTech could be an ASX growth share to buy. It has copped a heavy selloff this year — down around 40% from its 52-week high — following some short-term headwinds and concerns over growth expectations caused by internal drama. But zoom out, and the long-term story remains intact.
Its CargoWise platform is used by the world's largest freight and logistics operators, with massive runway still ahead as the company expands globally and vertically across the supply chain.
The business is profitable, cash-generative, and has a huge addressable market — and while near-term sentiment has taken a hit, those with patience could be well rewarded as WiseTech continues to embed itself into the global logistics ecosystem.
Goldman Sachs currently has a buy rating and $128.00 price target on its shares. This compares to its current share price of $84.83.
